Page last updated: 2024-08-26

rubidium and cyclin d1

rubidium has been researched along with cyclin d1 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anderson, BD; Brooks, HB; Campbell, RM; Conner, S; Considine, EL; DeHahn, TB; Dempsey, JA; Engler, TA; Faul, MM; Furness, K; Kirmani, K; Kolis, SP; Lytle, ML; Malhotra, S; Ogg, CA; Patel, B; Sanchez-Martinez, C; Schultz, RM; Shih, C; Spencer, CD; Stamm, NB; Sullivan, KA; Vasudevan, V; Watkins, SA; Xie, W; Zhou, X; Zhu, G	1

Other Studies

1 other study(ies) available for rubidium and cyclin d1

Article	Year
Novel, potent and selective cyclin D1/CDK4 inhibitors: indolo[6,7-a]pyrrolo[3,4-c]carbazoles. Bioorganic & medicinal chemistry letters, 2003, Jul-21, Volume: 13, Issue:14 Topics: Antineoplastic Agents; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Carbazoles; Cell Cycle; Cell Division; Cell Line, Tumor; Cyclic AMP-Dependent Protein Kinases; Cyclin D1; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinases; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Phosphorylation; Proto-Oncogene Proteins; Rubidium; Structure-Activity Relationship	2003

Article

Year

Novel, potent and selective cyclin D1/CDK4 inhibitors: indolo[6,7-a]pyrrolo[3,4-c]carbazoles.

Bioorganic & medicinal chemistry letters, 2003, Jul-21, Volume: 13, Issue:14

Topics: Antineoplastic Agents; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Carbazoles; Cell Cycle; Cell Division; Cell Line, Tumor; Cyclic AMP-Dependent Protein Kinases; Cyclin D1; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinases; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Phosphorylation; Proto-Oncogene Proteins; Rubidium; Structure-Activity Relationship

2003